Harvard Business Review
JULY 29, 2014
Break up a strategic function in response to underperformance in the wake of severe market disruptions? What would the capital markets look like today if a similar tack had been taken when the CFO role was ripe for transformation? The CHRO must step up to the implications of the new world of work.
Harvard Business Review
NOVEMBER 21, 2013
For many years, beginning in 1942, Premarin was the only hormone replacement therapy drug on the market derived from a natural source. A series of patents were issued on the drug in the 1940s, but long after they had expired, there were still no generic competitors on the market. Such was not the case.
Expert insights. Personalized for you.
9 
Let's personalize your content